Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag 
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Philip Morris International Inc. (NYSE: PM) is reportedly exploring the sale of its cigar business for over $1 billion, according to Bloomberg. The move aligns with the tobacco giant’s strategy to transition toward smoke-free products.
Philip Morris acquired the cigar unit through its 2022 purchase of Swedish Match, a deal aimed at expanding its smoke-free portfolio. Since then, the company has successfully introduced Swedish Match’s popular ZYN nicotine pouches in the U.S., fueling strong demand.
Despite this shift, traditional cigarettes, particularly the iconic Marlboro brand, remain a key revenue driver. While Philip Morris is pushing alternatives in the U.S., international sales still rely heavily on cigarette demand, especially in emerging markets.
The company recently reported better-than-expected fourth-quarter earnings and provided an optimistic outlook for 2025. Its IQOS smoke-free device is also gaining traction in the U.S., following FDA approval in early 2024.
With growing demand for smoke-free alternatives, Philip Morris’ potential cigar business sale marks another step in its transformation strategy.
